Carlsmed Inc (CARL) financials
Carlsmed revenue and earnings by year
Carlsmed's revenue was $50.5 million in the fiscal year to December 31, 2025, up 85.9% from the year before. Net income was -$29.6 million, -58.7% of revenue.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 3 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 51 | 27 | 14 |
| Revenue growth | 85.9% | 97.2% | — |
| Gross profit | 38 | 20 | 10 |
| Gross margin | 75.3% | 73.8% | 71.9% |
| Operating income | -31 | -24 | -19 |
| Operating margin | -60.5% | -88.8% | -134.9% |
| Net income | -30 | -24 | -19 |
| Net margin | -58.7% | -89.3% | -137.2% |
| Free cash flow | -30 | -26 | -18 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CARL in Markets.
See also: CARL returns
No forecast, no recommendation. This page describes Carlsmed Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.